Amid ADHD drug shortage, FDA approves generic version of medication: 'Opportune time'
Fox News
Amid the shortage of ADHD medications, the FDA has approved several generic versions of Vyvanse for the treatment of attention-deficit/hyperactivity disorder in people 6 years and older.
Dr. Barry K. Herman, a board-certified psychiatrist and the chief medical officer for Mentavi Health, a mental health assessment provider in Grand Rapids, Michigan, is hopeful that these new generic drugs will help address the persistent ADHD medication shortage. Melissa Rudy is health editor and a member of the lifestyle team at Fox News Digital.
"The FDA made the review and approval of these generics a priority, and hopefully manufacturing will now scale up rapidly to meet this pressing need," he told Fox News Digital.
More Related News